Patents by Inventor Johnny Habchi

Johnny Habchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of identifying novel protein aggregation inhibitors based on chemical kinetics
    Patent number: 11536729
    Abstract: The subject matter disclosed herein relates to methods of identifying pharmacophores and inhibitors against protein aggregation. The present disclosure also provides pharmacophores themselves and medical uses of agents in the treatment of diseases associated with protein aggregation.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: December 27, 2022
    Assignee: CAMBRIDGE ENTERPRISE LIMITED
    Inventors: Christopher Dobson, Tuomas Knowles, Michele Vendruscolo, Johnny Habchi, Sean Chia
  • THERAPY FOR PROTEIN MISFOLDING DISEASE
    Publication number: 20210145801
    Abstract: A thiazolidinedione or rhodanine compound or a pharmaceutically acceptable salt, tautomer, solvate, hydrate, prodrug, derivative, stereoisomer, analog or isotopically labelled derivative thereof, for use in the treatment and/or prevention of a protein misfolding disease, wherein said compound is not Pioglitazone, Rosiglitazone, Rivoglitazone, Balaglitazone or Mitoglitazone.
    Type: Application
    Filed: April 4, 2019
    Publication date: May 20, 2021
    Inventors: Johnny HABCHI, Xiaoting YANG, Kerry JENKINS, Michele PERNI, Sunehera SARWAT, Joseph MENZIES, Cristina CAMPERO PEREDO, Andrea POSSENTI, Sara LINSE, Tuomas KNOWLES, Christopher DOBSON, Samuel COHEN, Michele VENDRUSCOLO
  • THERAPY FOR OPHTHALMOLOGICAL CONDITIONS
    Publication number: 20210145802
    Abstract: A thiazolidinedione or rhodanine compound or a pharmaceutically acceptable salt, tautomer, solvate, hydrate, prodrug, derivative, stereoisomer, analog or isotopically labelled derivative thereof, for use in the treatment and/or prevention of an ophthalmological condition, wherein said compound is not Pioglitazone, Rosiglitazone, Rivoglitazone, Balaglitazone or Mitoglitazone.
    Type: Application
    Filed: April 4, 2019
    Publication date: May 20, 2021
    Inventors: Johnny HABCHI, Xiaoting YANG, Kerry JENKINS, Michele PERNI, Sunehera SARWAT, Joseph MENZIES, Cristina CAMPERO PEREDO, Andrea POSSENTI, Sara LINSE, Tuomas KNOWLES, Christopher DOBSON, Samuel COHEN, Michele VENDRUSCOLO
  • METHOD OF IDENTIFYING NOVEL PROTEIN AGGREGATION INHIBITORS BASED ON CHEMICAL KINETICS
    Publication number: 20180306813
    Abstract: The present invention relates to methods of identifying pharmacophores and inhibitors against protein aggregation. The present invention also provides pharmacophores themselves and medical uses of agents in the treatment of Alzheimer's.
    Type: Application
    Filed: December 28, 2016
    Publication date: October 25, 2018
    Inventors: Christopher Dobson, Tuomas Knowles, Michele Vendruscolo, Johnny Habchi, Sean Chia